Gastrointestinal Motility Disorder
17
3
4
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.8%
2 terminated out of 17 trials
75.0%
-11.5% vs benchmark
6%
1 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (17)
Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
"The Effect of Abdominal Massage on Gastrointestinal Functions in Mechanically Ventilated Patients Receiving Enteral Nutrition in Intensive Care"
Short-term Effect of Exercise and Self-manual Approaches to Bloating - Distention
The Effect of Foot Reflexology After Cesarean Section
Intestinal Dysmotility in Patients With Functional Digestive Symptoms
The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity
Gastrointestinal Motor Disorders (Esophageal and Anorectal) After COVID-19
Oropharyngeal Administration of Mother's Milk in Preterm Infants and Gastrointestinal Motility
Lanreotide in the Treatment of Small Bowel Motility Disorders
Gastrointestinal Motility Among Diabetes Patients
A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades
Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water
Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?